CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 6,393 shares at $6.78 ($43,330)
- 4 Planned sale Chief Financial Officer sold 2,792 shares at $8.76 ($24,446)
- 4 Planned sale Chief Executive Officer sold 7,134 shares at $8.76 ($62,465)
- 4 Grant or award Chief Medical Officer acquired 27,200 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 27,500 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 68,100 shares (grant or award)
- 4 Open-market buy 10% owner bought 350,000 shares at an average $20.01 ($7,003,761)
- 4 Grant or award Director acquired 5,566 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Financial Officer sold 18,043 shares at an average $47.88 ($863,838)
- 4 Planned sale Chief Executive Officer sold 63,358 shares at an average $46.57 ($2,950,518)
- 4 Exercise or conversion Director acquired 1,667 shares (option exercise)
- 4 Grant or award Director acquired 2,783 shares (grant or award)
- 4 Grant or award Director acquired 2,783 shares (grant or award)
- 4 Grant or award Director acquired 2,783 shares (grant or award)
- 4 Grant or award Director acquired 2,783 shares (grant or award)
- 4 Grant or award Director acquired 2,783 shares (grant or award)
- 4 Grant or award Director acquired 2,783 shares (grant or award)
- 4 Grant or award Director acquired 2,783 shares (grant or award)
Page 3 of 17 · 340 filings